Michael Gibertini has more than 30 years’ experience in clinical research, focused primarily in psychometrics, clinical trial design, and drug development for CNS disorders. Gibertini has held multiple clinical and research positions in academia, the pharmaceutical industry, and CROs. His recent work has been as an executive at INC Research, now Syneos Health, where he served as head of CNS Clinical Development for over a decade, followed by appointments as head of clinical development and chief operating officer.
Gibertini is now a consultant and serving as senior advisor to Syneos Health and Elligo Health Research. He holds a PhD from the University of Houston in clinical psychology and has post-doctoral training in psychoneuroimmunology.